It's likely that Direct has been slightly postponed due to the delay in MHRA approval of -L. LP was likely expecting approval last year, which would've helped provide funding to restart Direct in January. If it hasn't restarted yet, then Direct will restart soon after DCVax-L approval. IMO
How does this even make sense....they need money to launch. They don't have money to do BOTH launch and run trials. They will be lucky to be in the green in this non-reiubursement market. But whatever....more BS from you. BS2020.